

( (S (NP-SBJ (NP Institut Merieux S.A.)
             (PP of
                 (NP France)))
     (VP said
         (SBAR 0
               (S (NP-SBJ the Canadian government)
                  (VP raised
                      (NP (NP an obstacle)
                          (PP to
                              (NP (NP its proposed acquisition)
                                  (PP of
                                      (NP Connaught BioSciences Inc.))
                                  (PP for
                                      (NP (NP (QP 942 million) Canadian dollars)
                                          (PRN -LRB-
					       (NP (QP US$ 801.6 million) *U*)
					       -RRB-))))))))))
     .))
( (S (NP-SBJ Merieux)
     (VP said
         (SBAR 0
               (S (NP-SBJ (NP (NP the government 's)
			      minister)
                          (PP of
                              (NP industry
                                  ,
                                  science
                                  and
                                  technology)))
                  (VP told
                      (NP it)
                      (SBAR that
                            (S (NP-SBJ he)
                               (VP was n't
                                   (ADJP-PRD convinced
                                             (SBAR that
                                                   (S (NP-SBJ-1 the purchase)
                                                      (VP is
                                                          (ADJP-PRD likely
                                                                    (S (NP-SBJ *-1)
                                                                       (VP to
                                                                           (VP be
                                                                               (PP-PRD of
										       ``
										       (NP net benefit)
										       '')
									       (PP to
										   (NP Canada)))))))))))))))))
     .))
( (S (NP-SBJ Canadian investment rules)
     (VP require
         (SBAR that
               (S (NP-SBJ big foreign takeovers)
                  (VP meet
                      (NP that standard)))))
     .))
( (S (NP-SBJ The French company)
     (VP said
         (SBAR 0
               (S (NP-SBJ the government)
                  (VP gave
                      (NP it)
                      (NP (NP 30 days)
                          (SBAR (WHPP-1 in
					(WHNP which))
				(S (NP-SBJ *)
				   (VP to
				       (VP submit
					   (NP (NP information)
					       (SBAR (WHNP-2 0)
						     (S (NP-SBJ *T*-2)
							(VP to
							    (ADVP further)
							    (VP support
								(NP its takeover plan))))))
					   (PP-TMP *T*-1))))))))))
     .))
( (S (NP-SBJ Both
             Merieux
             and
             Connaught)
     (VP are
         (NP-PRD biotechnology research
                 and
                 vaccine manufacturing
                 concerns))
     .))
( (S (NP-SBJ (NP The government 's)
             action)
     (VP was
         (ADJP-PRD unusual))
     .))
( (S (NP-SBJ (NP Alan Nymark)
             ,
             (NP (NP executive vice president)
                 (PP of
                     (NP (NP Investment Canada)
                         ,
                         (SBAR (WHNP-1 which)
                               (S (NP-SBJ *T*-1)
                                  (VP oversees
                                      (NP foreign takeovers))))
                         ,))))
     (VP said
         (SBAR 0
               (S (NP-SBJ it)
                  (VP marked
                      (NP (NP the first time)
                          (PP-LOC in
				  (NP its four-year history))
                          (SBAR (WHADVP-2 that)
                                (S (NP-SBJ the agency)
                                   (VP has
                                       (VP made
                                           (NP (NP an adverse net-benefit decision)
                                               (PP about
						   (NP (NP the acquisition)
						       (PP of
							   (NP a
							       (ADJP publicly traded)
							       company)))))
					   (ADVP-TMP *T*-2))))))))))
     .))
( (S (NP-SBJ He)
     (VP said
         (SBAR 0
               (S (NP-SBJ it)
                  (VP has
                      (VP (VP reached
                              (NP (NP the same conclusions)
                                  (PP about
                                      (NP some attempts
                                          (S (NP-SBJ *)
                                             (VP to
                                                 (VP buy
                                                     (ADJP closely held)
                                                     concerns)))))))
                          , 
			  but
			  (VP (ADVP-TMP eventually)
			      allowed
			      (S (NP-SBJ those acquisitions)
                                 (VP to
                                     (VP proceed)))))))))
     .))
( (SINV ``
	(S-TPC-2 (S (NP-SBJ This)
		    (VP is n't
			(NP-PRD (NP a change)
				(PP-LOC in
					(NP government policy)))))
		 ;
		 (S (NP-SBJ-1 this provision)
		    (VP has
			(VP been
			    (VP used
				(NP *-1)
				(ADVP-TMP before))))))
	,
	''
	(VP said
	    (S *T*-2))
	(NP-SBJ (NP Jodi Redmond)
		,
		(NP (NP press secretary)
		    (PP for
			(NP (NP Harvie Andre)
			    ,
			    (NP (NP (NP Canada 's)
				    minister)
				(PP of
				    (NP industry
					,
					science
					and
					technology)))))))
	.))
( (S (NP-SBJ Mr. Andre)
     (VP issued
         (NP the ruling)
         (PP based
	     (PP on
		 (NP (NP a recommendation)
		     (PP by
			 (NP Investment Canada))))))
     .))
( (S (NP-SBJ (NP Spokesmen)
             (PP for
                 (NP Merieux
                     and
                     Connaught)))
     (VP (VP said
             (SBAR 0
                   (S (NP-SBJ-1 they)
                      (VP had n't
                          (VP been
                              (VP informed
                                  (NP *-1)
                                  (PP-CLR of
					  (NP (NP specific areas)
					      (PP of
						  (NP concern))))
                                  (PP by
                                      (NP-LGS either
					      (NP the government)
					      or
					      (NP Investment Canada)))))))))
         , 
	 but
         (VP added
             (SBAR 0
                   (S (NP-SBJ-2 they)
                      (VP hope
                          (S (NP-SBJ *-2)
                             (VP to
                                 (VP have
                                     (NP more information)
				     (NP-TMP early this week)))))))))
     .))
( (S (NP-SBJ-1 Investment Canada)
     (VP declined
         (S (NP-SBJ *-1)
            (VP to
                (VP comment
                    (PP-CLR on
			    (NP (NP the reasons)
				(PP for
				    (NP the government decision))))))))
     .))
( (S (NP-SBJ (NP Viren Mehta)
             ,
             (NP (NP a partner)
                 (PP with
                     (NP (NP Mehta & Isaly)
                         ,
                         (NP a
                             (ADJP New York-based)
                             pharmaceutical industry research firm)
                         ,))))
     (VP said
         (SBAR 0
               (S (NP-SBJ (NP the government 's)
                          ruling)
                  (VP was n't
                      (ADJP-PRD unexpected)))))
     .))
( (S ``
     (S-TPC-1 (NP-SBJ This)
	      (VP has
		  (VP become
		      (NP-PRD (NP a
				  (ADJP very politicized)
				  deal)
			      ,
			      (PP concerning
				  (NP (NP Canada 's)
				      only
				      large , world-class 
				      (UCP bio-research or pharmaceutical)
				      company))))))
     ,
     ''
     (NP-SBJ Mr. Mehta)
     (VP said
	 (S *T*-1))
     .))
( (S (NP-SBJ Mr. Mehta)
     (VP said
         (SBAR 0
               (S (NP-SBJ (NP the move)
                          (SBAR (WHNP-1 that)
                                (S (NP-SBJ *T*-1)
                                   (VP could
                                       (VP allow
					   (S (NP-SBJ the transaction)
                                              (VP to
                                                  (VP go
                                                      (ADVP-DIR ahead)
                                                      (SBAR-MNR as
								(S (NP-SBJ-2 *)
								   (VP planned
								       (NP *-2))))))))))))
                  (VP could
                      (VP be
                          (NP-PRD (NP an out-of-court settlement)
                                  (PP of
                                      (NP (NP (NP Connaught 's)
					      dispute)
                                          (PP with
                                              (NP (NP the University)
                                                  (PP of
                                                      (NP Toronto))))))))))))
     .))
( (S (NP-SBJ-3 The University)
     (VP is
         (VP seeking
             (S (NP-SBJ *-3)
                (VP to
                    (VP block
                        (NP (NP the acquisition)
                            (PP of
                                (NP Connaught))
                            (PP by
                                (NP foreign interests))))))
	     ,
	     (S-ADV (NP-SBJ *-3)
		    (VP citing
			(NP (NP concerns)
			    (PP about
				(NP (NP the amount)
				    (PP of
					(NP research))
				    (SBAR (WHNP-4 that)
					  (S (NP-SBJ-2 *T*-4)
					     (VP would
						 (VP be
						     (VP done
							 (NP *-2)
							 (PP-LOC in
								 (NP Canada))))))))))))))
     .))
( (S (NP-SBJ The university)
     (VP is
         (VP considering
             (NP (NP a settlement proposal)
                 (VP made
                     (NP *)
                     (PP by
                         (NP-LGS Connaught))))))
     .))
( (S (SBAR-ADV While
	       (S (NP-SBJ neither side)
		  (VP will
		      (VP disclose
			  (NP its contents)))))
     ,
     (NP-SBJ Mr. Mehta)
     (VP expects
	 (S (NP-SBJ it)
            (VP to
                (VP contain
                    (NP (NP (ADJP more specific)
			    guarantees)
                        (PP on
                            (NP (NP research and development spending levels)
                                (PP-LOC in
					(NP Canada))))
                        (SBAR than
                              (S (NP-SBJ Merieux)
                                 (VP offered
				     (NP *?*)
                                     (PP-DTV to
					     (NP Investment Canada))))))))))
     .))
( (S (NP-SBJ (NP Some analysts)
             ,
             (PP such as
                 (NP (NP Murray Grossner)
                     (PP of
                         (NP Toronto-based
                             Richardson Greenshields Inc.))))
             ,)
     (VP believe
         (SBAR 0
               (S (NP-SBJ the government ruling)
                  (VP leaves
                      (S (NP-SBJ the door)
			 (ADJP-PRD open
				   (PP for
				       (NP (NP other bidders)
					   ,
					   (PP such as
					       (NP (NP (NP Switzerland 's)
						       Ciba-Geigy)
						   and
						   (NP (NP Chiron Corp.)
						       (PP of
							   (NP (NP Emeryville)
							       ,
							       (NP Calif))))))))))))))
     .))
( (S (NP-SBJ-1 (NP Officials)
               (PP for
                   (NP (NP the two concerns)
                       ,
                       (SBAR (WHNP-2 which)
                             (S (NP-SBJ *T*-2)
                                (VP are
                                    (VP bidding
                                        (NP (NP C$ 30 *U*)
                                            (NP-ADV a share))
                                        (PP-CLR for
						(NP Connaught)))))))))
     ,
     (VP could n't
         (VP be
             (VP reached
                 (NP *-1)
                 (PP-PRP for
			 (NP comment)))))
     .))
( (S (NP-SBJ (ADJP French state-owned)
             Rhone-Poulenc S.A.)
     (VP holds
         (NP (NP 51 %)
             (PP of
                 (NP Merieux))))
     .))
